EWA
CALT

EverSource Wealth Advisors’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

EverSource Wealth Advisors’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-125
Closed -$4.81K – 3147
2024
Q2 		$4.81K Buy
+125
New +$3.44K ﹤0.01% 2232

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

EverSource Wealth Advisors's CALT Position: Q3 2024 in Review

EverSource Wealth Advisors sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 125 shares — an estimated $4.81K sold.

EverSource Wealth Advisors first reported a position in CALT in Q2 2024 and held it in 1 quarter. The position peaked at $4.81K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • EverSource Wealth Advisors reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • EverSource Wealth Advisors sold 125 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $4.81K.
  • EverSource Wealth Advisors first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2024 and held it in 1 quarter.
  • EverSource Wealth Advisors's Calliditas Therapeutics AB American Depositary Shares position peaked at $4.81K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on EverSource Wealth Advisors's 13F filing for Q3 2024, filed 8 Nov 2024.